ISHARES TR's ticker is IBB and the CUSIP is 464287556. A total of 768 filers reported holding ISHARES TR in Q2 2020. The put-call ratio across all filers is 1.28 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $66,949 | -3.7% | 547 | 0.0% | 0.06% | +7.7% |
| Q2 2023 | $69,505 | -1.7% | 547 | 0.0% | 0.05% | -5.5% |
| Q1 2023 | $70,710 | -1.6% | 547 | 0.0% | 0.06% | +1.9% |
| Q4 2022 | $71,876 | +12.3% | 547 | 0.0% | 0.05% | -1.8% |
| Q3 2022 | $64,000 | 0.0% | 547 | 0.0% | 0.06% | +7.8% |
| Q2 2022 | $64,000 | -9.9% | 547 | 0.0% | 0.05% | +8.5% |
| Q1 2022 | $71,000 | -15.5% | 547 | 0.0% | 0.05% | -11.3% |
| Q4 2021 | $84,000 | -5.6% | 547 | 0.0% | 0.05% | -19.7% |
| Q3 2021 | $89,000 | -1.1% | 547 | 0.0% | 0.07% | 0.0% |
| Q2 2021 | $90,000 | -1.1% | 547 | -9.3% | 0.07% | -9.6% |
| Q1 2021 | $91,000 | 0.0% | 603 | 0.0% | 0.07% | -6.4% |
| Q4 2020 | $91,000 | +11.0% | 603 | 0.0% | 0.08% | +5.4% |
| Q3 2020 | $82,000 | 0.0% | 603 | 0.0% | 0.07% | -17.8% |
| Q2 2020 | $82,000 | +26.2% | 603 | 0.0% | 0.09% | +15.4% |
| Q1 2020 | $65,000 | -9.7% | 603 | 0.0% | 0.08% | +1.3% |
| Q4 2019 | $72,000 | – | 603 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atom Investors LP | 78,501 | $10,139,189 | 5.52% |
| Bronte Capital Management Pty Ltd. | 302,076 | $39,016,136 | 4.53% |
| Michelson Medical Research Foundation, Inc. | 43,395 | $5,604,898 | 4.40% |
| Hackensack Meridian Health, Inc. | 228,000 | $29,448,480 | 4.26% |
| DAFNA Capital Management LLC | 102,500 | $13,238,900 | 3.97% |
| Richmond Brothers, Inc. | 16,724 | $2,159,856 | 3.64% |
| Alpha Family Trust | 34,549 | $4,462,349 | 3.53% |
| HANSEATIC MANAGEMENT SERVICES INC | 11,897 | $1,537 | 3.46% |
| PURSUE WEALTH PARTNERS LLC | 37,789 | $4,880,827 | 3.33% |
| Rye Brook Capital LLC | 40,100 | $5,179 | 3.17% |